Skip to main content
. 2010 Feb 15;3(2):23–30. doi: 10.1097/WOX.0b013e3181d25eac

Figure 2.

Figure 2

Effect of albuterol and montelukast on the percent decrease in FEV1 after exercise challenge in 11 children (7-17 years) with exercise-induced asthma (defined as ≥ 15% drop in FEV1). Patients received 3-7 days of montelukast (5-10 mg/d) or 2 puffs of albuterol MDI just before exercise challenge and then were crossed over to the alternate treatment [8].